These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 15862109)
1. Morphinan neuroprotection: new insight into the therapy of neurodegeneration. Zhang W; Hong JS; Kim HC; Zhang W; Block ML Crit Rev Neurobiol; 2004; 16(4):271-302. PubMed ID: 15862109 [TBL] [Abstract][Full Text] [Related]
2. Regulation of neuroinflammation by herbal medicine and its implications for neurodegenerative diseases. A focus on traditional medicines and flavonoids. Suk K Neurosignals; 2005; 14(1-2):23-33. PubMed ID: 15956812 [TBL] [Abstract][Full Text] [Related]
3. Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase. Qian L; Xu Z; Zhang W; Wilson B; Hong JS; Flood PM J Neuroinflammation; 2007 Sep; 4():23. PubMed ID: 17880684 [TBL] [Abstract][Full Text] [Related]
4. Neuropsychopharmacological understanding for therapeutic application of morphinans. Shin EJ; Hong JS; Kim HC Arch Pharm Res; 2010 Oct; 33(10):1575-87. PubMed ID: 21052935 [TBL] [Abstract][Full Text] [Related]
5. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target. Kaminska B; Gozdz A; Zawadzka M; Ellert-Miklaszewska A; Lipko M Anat Rec (Hoboken); 2009 Dec; 292(12):1902-13. PubMed ID: 19943344 [TBL] [Abstract][Full Text] [Related]
6. Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications. Wilms H; Zecca L; Rosenstiel P; Sievers J; Deuschl G; Lucius R Curr Pharm Des; 2007; 13(18):1925-8. PubMed ID: 17584117 [TBL] [Abstract][Full Text] [Related]
7. P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases. Takenouchi T; Sekiyama K; Sekigawa A; Fujita M; Waragai M; Sugama S; Iwamaru Y; Kitani H; Hashimoto M Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):91-6. PubMed ID: 20143170 [TBL] [Abstract][Full Text] [Related]
8. NNZ-2566, a glypromate analog, improves functional recovery and attenuates apoptosis and inflammation in a rat model of penetrating ballistic-type brain injury. Lu XC; Chen RW; Yao C; Wei H; Yang X; Liao Z; Dave JR; Tortella FC J Neurotrauma; 2009 Jan; 26(1):141-54. PubMed ID: 19119917 [TBL] [Abstract][Full Text] [Related]
9. Catalpol attenuates the neurotoxicity induced by beta-amyloid(1-42) in cortical neuron-glia cultures. Jiang B; Du J; Liu JH; Bao YM; An LJ Brain Res; 2008 Jan; 1188():139-47. PubMed ID: 18022141 [TBL] [Abstract][Full Text] [Related]
11. An in vitro model of inflammatory neurodegeneration and its neuroprotection. Messmer K; Reynolds GP Neurosci Lett; 2005 Nov; 388(1):39-44. PubMed ID: 16102901 [TBL] [Abstract][Full Text] [Related]
12. Recent progress in therapeutic strategies for microglia-mediated neuroinflammation in neuropathologies. Gupta N; Shyamasundar S; Patnala R; Karthikeyan A; Arumugam TV; Ling EA; Dheen ST Expert Opin Ther Targets; 2018 Sep; 22(9):765-781. PubMed ID: 30138572 [TBL] [Abstract][Full Text] [Related]
13. Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat. Rosi S; Vazdarjanova A; Ramirez-Amaya V; Worley PF; Barnes CA; Wenk GL Neuroscience; 2006 Nov; 142(4):1303-15. PubMed ID: 16989956 [TBL] [Abstract][Full Text] [Related]
14. Duality of Antidepressants and Neuroprotectants. Tizabi Y Neurotox Res; 2016 Jul; 30(1):1-13. PubMed ID: 26613895 [TBL] [Abstract][Full Text] [Related]
15. Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage through inhibition of microglia activation and proinflammatory factors generation. Chen HQ; Jin ZY; Li GH Neurosci Lett; 2007 May; 417(2):112-7. PubMed ID: 17399896 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic Potential of Genipin in Central Neurodegenerative Diseases. Li Y; Li L; Hölscher C CNS Drugs; 2016 Oct; 30(10):889-97. PubMed ID: 27395402 [TBL] [Abstract][Full Text] [Related]
17. Inflammation in central nervous system injury. Allan SM; Rothwell NJ Philos Trans R Soc Lond B Biol Sci; 2003 Oct; 358(1438):1669-77. PubMed ID: 14561325 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of microglial inflammation by the MLK inhibitor CEP-1347. Lund S; Porzgen P; Mortensen AL; Hasseldam H; Bozyczko-Coyne D; Morath S; Hartung T; Bianchi M; Ghezzi P; Bsibsi M; Dijkstra S; Leist M J Neurochem; 2005 Mar; 92(6):1439-51. PubMed ID: 15748162 [TBL] [Abstract][Full Text] [Related]
19. PPARgamma as a therapeutic target in central nervous system diseases. Sundararajan S; Jiang Q; Heneka M; Landreth G Neurochem Int; 2006 Jul; 49(2):136-44. PubMed ID: 16766086 [TBL] [Abstract][Full Text] [Related]
20. Novel anti-inflammatory and neuroprotective agents for Parkinson's disease. Lu L; Li F; Wang X CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):232-40. PubMed ID: 20015029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]